Latest filing published 21 Dec 2017 for Abattis Bioceuticals Corp., €13k.
Peter Vicars Gordon is a declared insider of Abattis Bioceuticals Corp., with filings sourced from SEDI. Over a trading history stretching from 29 May 2017 to 20 December 2017, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 21 December 2017 with an option exercise (€13k) in Abattis Bioceuticals Corp. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations